Bone Marrow Stem Cell Treatment

Bone Marrow Used for Stem Cell Therapy Treatment

Did you know that your bone marrow can be used to help you promote healing tissue in your body? Bone marrow is rich with stem cells, and doctors are now able to extract stem cells from your bone marrow, process them, and reintroduce them into your body. For those suffering from debilitating lung diseases, the Lung Institute might be able to use this or another stem cell procedure to help rejuvenate damaged lung tissue for a better quality of life.

So how does bone marrow stem cell therapy work? Over the course of three days, a patient’s stem cells will be harvested from his or her bone marrow, processed and reintroduced into their body. After reintroduction, the stem cells can begin to slow down the progression of the disease and improve lung function. Everyone has stem cells in their own body that act the body’s system to promote healing. Extracting and reintroducing stem cells to certain damaged areas of the body accelerates this process.

What Can You Expect

The bone marrow procedure is a hybrid treatment that takes place over the course of three days in a clinical outpatient setting. Before treatment can begin, the patient must complete all bloodwork, paperwork and prerequisite testing, which typically includes an electrocardiogram (EKG) and a pulmonary function test. After this necessary evaluation, the patient can visit one of our state-of-the-art Lung Institute clinics to begin treatment.

For the next few days, the patient will spend a few hours in the clinic each day. On the first day of treatment, the patient will receive the venous procedure, which uses an IV to collect a blood sample. The second day consists of the bone marrow aspiration, which removes a small amount of bone marrow fluid. Each day, the clinicians will process the stem cells from the blood or bone marrow so that they can be reintroduced to the damaged area intravenously. After reintroduction, the stem cells can begin to promote healing and improve your lung function.

Patients are often surprised by the simplicity of these minimally invasive procedures, but with cutting-edge technology and a patient-centric clinical team, patients can rest assured that they are in good hands. Throughout the entire treatment process, patients have the opportunity to get any questions immediately answered by our knowledgeable medical staff. The Lung Institute clinical team remains in contact with patients after treatment and works together with the patient’s physician and pulmonologist to create a strong support system for the patient.

Follow-Up Care

On the last day of treatment, a Lung Institute clinician will assess the patient for discharge and outline what the next few weeks will look like in terms of follow-up care. Generally, the patient will receive a follow-up call at two weeks, three months and six months following his or her treatment. The patient is encouraged to return for a follow-up appointment with his or her pulmonologist at the three-month mark. At any time post-treatment, patients are welcome to contact their Patient Coordinator with questions and status updates.

If you or a loved one is suffering from a lung disease, contact us today at (800) 729-3065 to see if you qualify.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. The Lung Institute is firmly in accordance with the conditions set by the FDA for exemption status and conducts itself in full accordance with current guidelines. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and stem cell procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.